Literature DB >> 21944005

Current approaches to adjuvant therapy of melanoma.

Steinar Aamdal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21944005     DOI： 10.1016/S0959-8049(11)70193-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival.

Authors:  William E Carson; Joseph M Unger; Jeffrey A Sosman; Lawrence E Flaherty; Ralph J Tuthill; Mark J Porter; John A Thompson; Raymond A Kempf; Megan Othus; Antoni Ribas; Vernon K Sondak
Journal:  Cancer Immunol Res       Date:  2014-07-03       Impact factor: 11.151

2.  The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431.

Authors:  Vahid Salimi; Masoumeh Tavakoli-Yaraki; Mahmood Mahmoodi; Shahram Shahabi; Mohammad Javad Gharagozlou; Fazel Shokri; Talat Mokhtari-Azad
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

3.  Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.

Authors:  Christin Durchschein; Antje Hufner; Beate Rinner; Alexander Stallinger; Alexander Deutsch; Birgit Lohberger; Rudolf Bauer; Nadine Kretschmer
Journal:  Molecules       Date:  2018-10-30       Impact factor: 4.411

4.  Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That β-β-Dimethylacrylshikonin Leads to ROS Generation, Loss of Mitochondrial Membrane Potential, and Autophagy Induction.

Authors:  Nadine Kretschmer; Alexander Deutsch; Christin Durchschein; Beate Rinner; Alexander Stallinger; Juan Carlos Higareda-Almaraz; Marcel Scheideler; Birgit Lohberger; Rudolf Bauer
Journal:  Molecules       Date:  2018-10-30       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.